Indefinite Delivery Contract 36C24626D0018

Award Date 10/1/25
Last Date to Order 9/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) valued at $167,300 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, which has a period of performance through June 30, 2030, provides for the delivery of Roche LIAT consumables, including test kits and controls for COVID-19, Influenza A/B, RSV, and Group A Streptococcus testing, to the VA's Veterans...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The base contract, valued at $922,772, provides the VA with an ongoing vehicle to procure influenza A/B and COVID-19 testing supplies and services without socioeconomic set-asides. Under this IDC, the VA has issued multiple firm...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $1.56 million IDC, with a period of performance through June 2030, is for the service, maintenance, and supply of Roche Ventana instruments used by the VA's Veterans Integrated Service Network 16. This procurement was not set aside for any specific business...
The federal agency, the Department of Veterans Affairs Veterans Health Administration (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The IDC has a ceiling value of $667,159.30 and an ultimate completion date of August 31, 2030, for the provision of REAGENTS AND CONSUMABLES. Under this IDC, a $135,281.86...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The $487,747.35 BPA contract, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), will provide the VA with critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. The contract supports the provision of...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, with a total ceiling value of $133,203.95, covers the provision of Histology Special Stainer Testing services for the Buffalo VA Medical Center from October 1, 2025, through September 30, 2030. The initial task order,...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 (VISN 9), to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The single-award IDC has a ceiling value of $815,294.66 and a period of performance from October 1, 2021 to September 30, 2026. The contracted products and services include...

The Department of Veterans Affairs Veterans Health Administration, Network Contracting Office 6 has awarded a single award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, for the provision of histology consumables, test kits, reagents, and supplies. The $4.66 million contract, which runs from October 1, 2025 to September 30, 2026, will support six VA Medical Center laboratories and seven Health Care Centers across the VISN 6 network.

This brand-name only requirement was sole-sourced to Roche Diagnostics as the original equipment manufacturer and sole provider of the Ventana Roche H&E, IHC, and Benchmark Ultra systems currently owned and leased by the VISN laboratories. The contract covers a wide range of medical diagnostic technologies, including clinical chemistry analyzers, immunochemistry testing, molecular diagnostics, histology staining systems, point-of-care testing devices, and specialized reagents for conditions such as COVID-19, HIV, HPV, and other infectious and chronic diseases. This award will enable the VA to efficiently acquire Roche's diagnostic technologies through pre-negotiated pricing and terms to support healthcare delivery across the VA system.

Generated 10/2/25, 11:08 AM